Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6201-6208

  Biancone, Luigi ^a   Cantaluppi, Vincenzo ^a   Boccellino, Mariarosaria ^a   Del Sorbo, Lorenzo ^a   Russo, Simona ^a   Albini, Adriana ^b   Stamenkovic, Ivan ^c   Camussi, Giovanni ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 ANTIGEN; CELL ANTIGEN; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SIZE; CELL MIGRATION; CELL SIZE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD40; APOPTOSIS; CD40 LIGAND; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTEIN ENGINEERING; SARCOMA, KAPOSI; SOLUBILITY;

EID: 0033485624     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Paulie, S., A. Rosen, B. Ehlin-Henriksson, S. Braesch-Andersen, E. Jakobson, H. Koho, and P. Perlmann. 1989. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J. Immunol. 142:590.
2. Thomas, W. D., M. J. Smith, Z. Si, and P. Hersey. 1996. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int. J. Cancer 68:795.
3. Pammer, J., A. Plettenberg, W. Weninger, B. Diller, M. Mildner, A. Uthman, W. Issing, M. Sturzl, and E. Tschachler. 1996. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol. 148:1387.
4. Lollini, P. L., L. Landuzzi, F. Frabetti, I. Rossi, O. Nicoletti, K. Scotlandi, M. Serra, N. Baldini, C. De Giovanni, and P. Nanni. 1998. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells. Clin. Cancer Res. 4:1843.
5. Jakobson, E., G. Jonsson, P. Bjorck, and S. Paulie. 1998. Stimulation of CD40 in human bladder carcinoma cells inhibits anti- Fas/APO-1 (CD95)-induced apoptosis. Int. J. Cancer 77:849.
6. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159.
7. Van den Oord, J. J., A. Maes, M. Stas, J. Nuyts, S. Battocchio, A. Kasran, M. Garmyn, I. De Wever, and C. De Wolf-Peeters. 1996. CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am. J. Pathol. 149:1953.
8. Kluth, B., S. Hess, H. Engelmann, S. Schafnitzel, G. Riethmuller, and H. E. Feucht. 1997. Endothelial expression of CD40 in renal cell carcinoma. Cancer Res. 57:891.
9. Biancone, L., V. Cantaluppi, and G. Camussi. 1999. CD40-CD154 interaction in experimental and human disease. Int. J. Mol. Med. 3:343.
10. Mach, F., U. Schonbeck, R. P. Fabunmi, C. Murphy, E. Atkinson, J. Y. Bonnefoy, P. Graber, and P. Libby. 1998. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am. J. Pathol. 154:229.
11. Camussi, G., G. Montracchio, E. Lupia, A. De Martino, L. Perona, M. Arese, A. Vercellone, A. Toniolo, and F. Bussolino. 1995. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol. 154:6492.
12. Albini, A., I. Paglieri, G. Orengo, S. Carlone, M. G. Aluigi, R. De Marchi, C. Matteucci, A. Mantovani, F. Carozzi, S. Donini, and R. Benelli. 1997. The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11:713.
13. Biancone, L., G. Andres, H. Ahn, C. DeMartino, and I. Stamenkovic. 1995. Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis. Kidney Int. 48:458.
14. Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Andersen, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313.
15. Biancone, L., G. Andres, H. Ahn, A. Lim, C. Dai, R. Noelle, H. Yagita, C. DeMartino, and I. Stamenkovic. 1996. Distinct regulatory roles of lymphocyte costimulatory pathways on T-helper type-2 mediated autoimmune disease. J. Exp. Med. 183:1473.
16. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.
17. Roehm, N. W., G. H. Rodgers, S. M. Hayfield, and A. L. Glasebrook. 1991. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142:217.
18. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
19. Kroesen, B. J., G. Mesander, J.G. ter Harr, T. H. The, and L. de Leij. 1992. Direct visualization and quantification of cellular cytotoxicity using two color fluorescence. J. Immunol. Methods 156:47.
20. McGahon, A. J., S. J. Martin, R. P. Bissonnette, A. Mahboubi, Y. Shi, R. J. Mogil, W. K. Nishioka, and D. R. Green. 1995. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol. 46:153.
21. Sahagun, G., S. A. Moore, Z. Fabry, R. L. Schelper, and M. N. Hart. 1989. Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled Grifonia simplicifolia agglutinin. Am. J. Pathol. 134:1227.
22. Passaniti, A., R. M. Taylor, R. Pili, Y. Guo, P. V. Long, J. A. Haney, R. R. Pauly, D. S. Grant, and G. R. Martin. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:519.
23. Klaus, G. G., M. Holman, and J. Hasbold. 1994. Properties of mouse CD40: the role of homotypic adhesion in the activation of B cells via CD40. Eur. J. Immunol 24:2714.
24. Taub, M., Y. Wang, T. M. Szczesny, and H. K. Kleinman. 1990. Epidermal growth factor or transforming growth factor a is required for kidney tubulogenesis in Matrigel cultures in serum-free medium. Proc. Natl. Acad. Sci. USA 87: 4002.
25. Vukicevic, S., H. K. Kleinman, F. P. Luyten, A. B. Roberts, N. S. Roche, and A. H. Reddi. 1992. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res. 202:1.
26. Santos, O. F. P., and S. K. Nigam. 1993. HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-β. Dev. Biol. 160:293.
27. Kibbey, M. C., D. S. Grant, and H. K. Klieinman. 1992. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst. 84:1633.
28. Pietravalle, F., S. Lecoanet-Henchoz, H. Blasey, J. P. Aubry, G. Elson, M. D. Edgerton, J. Y. Bonnefoy, and J. F. Gauchat. 1996. Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J. Biol. Chem. 271:5965.
29. Graf, D., S. Muller, U. Korthauer, C. van Kooten, C. Weise, and R. A. Kroczek. 1995. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25:1749.
30. Mach, F., U. Schonbeck, G.K. Sukhova, T. Bourcier, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94:1931.
31. Slupsky, J. R., M. Kalbas, A. Willuweit, V. Henn, R. A. Kroczek, and G. Muller-Berghaus. 1998. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb. Haemostasis 80:1008.
32. Kim, Y. J., L. Borsig, N. M. Varki, and A. Varki. 1998. P-selectin deficiency attenuates tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 95:9325.